Lok Sabha Question No. 95 (STARRED), answered on 2016-11-22
Subject: Development of Pharma Industry
Ministry: CHEMICALS AND FERTILIZERS
Asked by: ARVIND GANPAT SAWANT

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

## LOK SABHA

## STARRED QUESTION No. 95

## TO BE ANSWERED ON THE 22 nd  November, 2016

## Development of Pharma Industry

*95. SHRI ARVIND SAWANT:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a)  whether  there  has  been  adequate  development  of  pharmaceutical industry  in  the  last  few  years  and  if  so,  the  rate  of  growth  of  the  said industry during the last three years and the current year, State-wise;
- (b) the rate of growth in production and rise in price of medicines during the above period; and
- (c) whether a variation in the rate of growth in manufacturing of medicines under  the  scheduled  and  non-scheduled  categories  of  drugs  has  been observed and if so, the details thereof, category-wise?

## ANSWER

## MINISTER IN THE MINISTRY OF CHEMICALS AND FERTILIZERS AND PARLIAMENTARY AFFAIRS (SHRI ANANTHKUMAR)

(a) to (c): A statement is laid on the Table of the House.

xxxxxx

## Statement  referred  to  in  reply  to  LOK  SABHA  STARRED  QUESTION No. 95 to be answered on 22 nd November, 2016 regarding Development of Pharma Industry

- (a): As  per  the  Pharmatrac  Data  available  with  National  Pharmaceutical Pricing  Authority  and  data  provided  by  Pharmaceuticals  Export  Promotion Council  of  India  (Pharmexcil),  a  body  under  the  Ministry  of  Commerce, the Annual Turnover during the last three years is as under:
- (b): In turnover terms the Pharmaceutical Industry has registered a growth from 12.01% during the financial year 2013-14 to 28.96 % during 2015-16. For the Pharmaceutical Industry as a whole, there is no monitorable parameter of  price  increase  or  decrease.  However,  according  to  the  provision  of  Drugs (Prices Control) Order-2013, the manufacturers of the medicines appearing in National  List  of  Essential  Medicines-2015  are  permitted  to  increase  the Maximum Retail Price (MRP) of these medicines once in a year, in the month of April on the basis of the Wholesale Price Index (WPI) with respect to previous calendar year. The manufacturer of the medicines not listed under National List of Essential Medicines-2015 is permitted to increase the Maximum Retail Price of  the  medicines  not  more  than  ten  percent  of  Maximum  Retail  Price  during preceding twelve months.
- (c): No such comparative study has been carried out.

| Particulars                                    |   Financial Year 2013 - 14 |   Financial Year 2014 - 15 |   Financial Year 2015 - 16 |   % Variation (from 13- 14 to 14- 15) |   % Variation (from 14- 15 to 15- 16) |   % Variation (from 13 - 14 to 15- 16) |
|------------------------------------------------|----------------------------|----------------------------|----------------------------|---------------------------------------|---------------------------------------|----------------------------------------|
| Turnover of Indian Pharma Industry (in crores) |                     158671 |                     177735 |                     204627 |                                 12.01 |                                 15.13 |                                  28.96 |

xxxxx